Form 8-K - Current report:
SEC Accession No. 0001641172-25-011939
Filing Date
2025-05-21
Accepted
2025-05-21 17:25:26
Documents
13
Period of Report
2025-05-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 42336
2 EX-10.1 ex10-1.htm EX-10.1 65997
  Complete submission text file 0001641172-25-011939.txt   286529

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE nrxs-20250515.xsd EX-101.SCH 3014
4 XBRL LABEL FILE nrxs-20250515_lab.xml EX-101.LAB 34239
5 XBRL PRESENTATION FILE nrxs-20250515_pre.xml EX-101.PRE 22358
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3830
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 25974096
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)